Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Semax

ACTH(4-10) analogue, Heptapeptide SEMAX

Quick Stats
Studies 172
Trials 37
Enrolling By Invitation NA INTERVENTIONAL NCT07264231

Exercise During Pregnancy: Effects on the Maternal-Fetal Unit

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

Metabolic alterations during pregnancy have been associated with adverse maternal-fetal outcomes, including low birth weight and pregnancy complications. Maternal endothelial dysfunction, oxidative stress, insulin resistance, and placental mitochondrial dysfunction are thought to contribute to fetal metabolic disturbances. Lifestyle changes, such as structured exercise during pregnancy, may modulate maternal and placental factors. This randomized controlled trial will evaluate the effects of a multicomponent exercise program during the second and third trimester on maternal functional capacity, vascular health, anthropometry, metabolic biomarkers, placental function, and newborn health outcomes.

Detailed Description

To investigate the effects of a multicomponent supervised exercise program during pregnancy on the maternal-fetal unit.

Interventions

Name: Intervention
Type: BEHAVIORAL
Description: Exercise

Primary Outcomes

Measure: Cardiorespiratory fitness (Vo2max)
TimeFrame: at the 16th and 34-36th week of gestation
Description: The modified cycle protocol will be performed to estimate maximal oxygen uptake (VO2max), and will be used as measure of cardiorespiratory fitness.
Measure: Maternal weight gain (kg)
TimeFrame: 34-36th week of gestation
Description: Maternal weight gain will be defined as the weight change from baseline measurement to the last measurement

Trial Information

NCT ID

NCT07264231

Status

Enrolling By Invitation

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

Universidad Pública de Navarra

Last Updated

December 15, 2025